Abstract
Purpose:
To evaluate feasibility, accuracy, and repeatability of suprathreshold Saccadic Vector Optokinetic Perimetry (SVOP) by comparison with Humphrey Field Analyzer (HFA) perimetry.
Methods:
The subjects included children with suspected field defects (n = 10, age 5–15 years), adults with field defects (n = 33, age 39–78 years), healthy children (n = 12, age 6–14 years), and healthy adults (n = 30, age 16–61 years). The test protocol comprised repeat suprathreshold SVOP and HFA testing with the C-40 test pattern. Feasibility was assessed by protocol completeness. Sensitivity, specificity, and accuracy of SVOP was established by comparison with reliable HFA tests in two ways: (1) visual field pattern results (normal/abnormal), and (2) individual test point outcomes (seen/unseen). Repeatability of each test type was assessed using Cohen's kappa coefficient.
Results:
Of subjects, 82% completed a full protocol. Poor reliability of HFA testing in child patients limited the robustness of comparisons in this group. Sensitivity, specificity, and accuracy across all groups when analyzing the visual field pattern results was 90.9%, 88.5%, and 89.0%, respectively, and was 69.1%, 96.9%, and 95.0%, respectively, when analyzing the individual test points. Cohen's kappa coefficient for repeatability of SVOP and HFA was excellent (0.87 and 0.88, respectively) when assessing visual field pattern results, and substantial (0.62 and 0.74, respectively) when assessing test point outcomes.
Conclusions:
SVOP was accurate in this group of adults. Further studies are required to assess SVOP in child patient groups.
Translational Relevance:
SVOP technology is still in its infancy but is used in a number of centers. It will undergo iterative improvements and this study provides a benchmark for future iterations.
The study adhered to the tenets of the Declaration of Helsinki and was approved by the South East Scotland Research Ethics Committee, NHS Lothian. Informed consent was obtained from all participants and their parent or guardian as required.
An unselected nonconsecutive series of children and adult patients in Edinburgh attending the ophthalmology clinic at the Royal Hospital for Sick Children or visual field assessment clinics at the Princess Alexandra Eye Pavilion, respectively, were recruited. Included patients had known or suspected visual field defects. A similar number of healthy subjects were recruited who had no history of ophthalmological or neurological disease likely to cause a visual field defect. Children included in the study were aged 5 to 15 years and adults were 16 years or older. Subjects with severe eye movement disorders which might preclude accurate SVOP testing were excluded from the study, but cases with strabismus and/or nystagmus were included.
The SVOP system used was a research prototype device (
Fig. 1). It comprised a personal computer (Dell Precision 380 workstation; Dell, Round Rock, TX), a 20″ patient display screen (Dell 2005FPW), and an eye tracker (X50; Tobii Technology, Stockholm, Sweden). The position of the patient display screen could be adjusted for different patient heights and a secondary display screen (out of sight from the patient) was used by the operator to input patient details, set-up tests, and monitor test progress. The only task required of the subject was to follow their natural reaction to visually fixate towards the area where visual field “test stimuli” were presented. A software algorithm automatically determined if subjects could perceive the test stimuli based on the direction and amplitude of a subject's eye gaze response.
29 The eye tracker was noncontact and provides “real time” (sample rate of 50 Hz and typical latency of 25–35 ms) data on: (1) three-dimensional (3D) eye position relative to the eye tracker, and (2) the point of gaze on the display screen. This allows: (1) the screen coordinates of visual field stimuli to be calculated in “real time,” and (2) patient eye gaze responses to visual field stimuli to be automatically assessed in “real time.”
Subjects were positioned in front of the patient display screen using appropriate seating for their age. The screen was positioned such that the subject's eyes were located approximately centrally in front of the display screen and 55 to 60 cm away from the eye tracker's camera. This procedure was aided using an on-screen graphic, which provided a real-time representation of the location of the subject's eyes.
Prior to each SVOP test, a calibration procedure was performed in which subjects were required to follow a visual stimulus with their gaze to five different screen locations. This procedure allowed characteristics of the subject's eyes (such as pupil position and shape) to be determined and used together with a mathematical 3D eye model in order to produce accurate gaze position data for that subject. The calibration stimulus used was a circle with a central dot, which moved to each location in a random order.
The visual field test stimuli were all of size Goldmann III (0.43° angular diameter) and duration 200 ms. By using a calibrated patient display screen, stimuli of defined luminance levels were produced using a process, which has since been refined further.
31 A luminance level equivalent to 14 dB on the HFA (stimulus and background luminance of 137 and 10 cd/m
2, respectively) was used in this suprathreshold test. Participants were given the simple instruction “If you see anything flash up on the screen look at it or where you thought it flashed up.”
A test pattern consisting of 41 test points (
Fig. 2) was employed. This test pattern is equivalent to the HFA's C-40 screening test patterns with the addition of a test point located at the natural blind spot (positioned 15° temporally and 1.5° below the midline).
The full test protocol was completed by 82% of the subjects participating in this study. The majority of those with an incomplete protocol were children and adult patients. Of healthy controls, 87% completed the full protocol. In the adult patient group the main reason for incomplete protocol was difficulties in obtaining accurate eye tracking data. The eye tracker used in this SVOP system was purchased off-the-shelf and was designed for a normal population. Our data supports this as no eye tracking problems were noted in the healthy groups in this study. Poor eye tracking can occur when the quality of the image of the pupil margin and corneal reflex is impaired due to factors such as: (1) dry eye and reduced ocular surface integrity, (2) spectacles, (3) irregular pupil shape, (4) strabismus, (5) nystagmus, and (6) eye makeup.
37 Many of these potential reasons are more likely to appear in an ophthalmology patient population. The eye tracker used in this study is now no longer produced by the manufacturer. Newer models have introduced proprietary developments to improve eye tracking, however the detail of these improvements is not known and further testing on patient groups, as well as collaboration with eye tracking manufacturers, is required in order to better understand these issues. Despite this limitation, the majority of the cohort had good quality eye tracking data and complete test protocols.
In the child patient group, 59% of first session SVOP tests were at least 95% complete, and in healthy children 96% of first SVOP tests were at least 95% complete. This compares favorably with a study performed by Tailor et al.,
32 in which only 12.5% of child patients completed a 40-point SVOP test. The children in the Tailor et al.
32 study had quite severe neurodisability. The sensory and motor reflex loop required to generate an accurate saccadic response to a peripheral stimulus is complex, and involves a variety of cortical and subcortical pathways. It is perhaps not surprising that the performance of SVOP will be less satisfactory in children with widespread abnormalities of the central nervous system.
Many of the HFA tests performed by children were rejected due to high rates of false-positive responses and fixation losses. These problems are frequently noted when performing static SAP with children. In this study, the children were naïve users of both the HFA and SVOP tests and no training was provided for either test. In future studies, it would be useful to give a child more time to practice the HFA test to enable a higher rate of reliable results, which can be used in the analysis. These HFA test reliability data demonstrate the inherent problems children have when performing SAP. SVOP can overcome some of these issues. For example, if an individual has poor fixation and is trying to scan and search for the next test stimulus, the SVOP test will not proceed until fixation is maintained on the fixation stimulus. In this way, the test is unlikely to have any fixation losses and fixation itself controls the test. However, a problem with this method is that the test can take longer to perform if the subject has inaccurate fixation or is prone to scanning and searching.
While SVOP was originally designed for children, the aim of this study was to assess the accuracy and reproducibility of SVOP as a visual field assessment technique generally. This required the use of equivalent, accurate HFA tests for comparison. Due to the exclusion of unreliable HFA tests, the analysis performed on the child groups was not robust and due to the iterative nature of the technology it is not possible to add more children to this study. In future SVOP studies involving children an increased number of participants is required, and alternative forms of visual field test comparison are needed. Tailor et al.
32 found there was 50% clinical agreement between SVOP and confrontation fields in young children, and 64.7% clinical agreement between SVOP and Goldman visual fields in older children. In our study, sensitivity and specificity for SVOP compared with HFA were 91% and 89% in adults. Testing children remains challenging and work is ongoing to improve the decision algorithms used in SVOP while at the same time eye tracking technology also continues to advance.
Using the HFA visual fields as a reference standard to assess its accuracy, SVOP had an overall (across all subject groups) sensitivity and specificity of 91% and 89%, respectively, when assessing the entire visual field as abnormal or normal. A limitation of this analysis method is that a visual field could be abnormal in one particular area with one test and in an entirely different area of the visual field with the other test but the outcome of both would be abnormal. In light of this, a more specific comparison was made by comparing all individual test points. By analyzing the data in this way SVOP had an overall sensitivity and specificity of 69% and 97%, respectively. Overall the reproducibility of the HFA and SVOP tests was categorized as ‘excellent' (Cohen's kappa of 0.80 and 0.83, respectively) when assessing the full visual field result as normal or abnormal. When assessing the individual visual field points, the reproducibility of SVOP and HFA were both categorized as ‘substantial' but with HFA scoring higher than SVOP (Cohen's kappa of 0.74 and 0.62, respectively).
The SVOP tests were significantly faster than the HFA tests in the healthy groups but slower in the patient groups. One reason for this is retesting of unseen points. Both the SVOP and the HFA suprathreshold tests retest points if they are initially unseen, however it is not known if the HFA retests all initially unseen points or if it uses a more sophisticated algorithm to determine if points need to be retested. Additionally, the SVOP test has a static time-period during which it waits for an eye movement response to visual field stimuli before deciding that a stimulus is unseen. The HFA uses a dynamic time-period, which reduces as the test progresses if the subject has a reliable response time. These practices could be added to SVOP in order to improve test times further, however the data from the normal subjects demonstrates that perimetry using eye movements has the potential to be faster than that which uses a button press.
One limitation of the test time data analyzed is that it does not take into account the time taken to set up testing for either type of test. Each test requires the patient be initially positioned and instructed. Additionally SVOP requires an eye tracking calibration sequence (lasting approximately 20 seconds) and HFA tests also requires an eye tracking calibration if its fixation monitoring functionality is used. These times were not analyzed in this study.
Using equivalent HFA tests as a reference standard, suprathreshold SVOP was an accurate visual field test in this group of adults. Further studies using alternative reference standards for children are required in order to assess SVOP in child patient groups and this is crucial as the technology matures. This study has shown that it is possible to use saccades as a response mechanism in perimetry. This has also been demonstrated by other groups using eye movement perimetry (EMP).
38 In addition, using saccades as the response mechanism may provide an additional measure for assessing glaucoma due to the increased saccadic reaction times seen in glaucoma patients as compared with healthy controls.
39 The results of this study provide a benchmark for future iterations of the SVOP technique.
The authors thank the staff within the Children's Clinical Research Facility at the Royal Hospital for Sick Children (RHSC) in Edinburgh and also Jane Andrews for her role as clinical coordinator.
Supported by grants from the Mackay bequest, Action Medical Research (AP1226), The RS Macdonald Charitable Trust, and the Wellcome Trust (049574).
Disclosure: I.C. Murray, author on a patent licensed to i2eye Diagnostics Ltd. (in liquidation), the company who have produced a commercial version of SVOP; L.A. Cameron, None; A.D. McTrusty, None; A. Perperidis, None; H.M. Brash, author on the aforementioned patent; B.W. Fleck, author on the aforementioned patent and director of i2Eye Diagnostics; R.A. Minns, author on the aforementioned patent and director of i2Eye Diagnostics